Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act

An Act to establish a Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

This bill was previously introduced in the 41st Parliament, 1st Session.

Sponsor

Kirsty Duncan  Liberal

Introduced as a private member’s bill. (These don’t often become law.)

Status

Introduced, as of Oct. 16, 2013

Subscribe to a feed of speeches and votes in the House related to Bill C-410.

Summary

This is from the published bill. The Library of Parliament often publishes better independent summaries.

This enactment requires the Minister of Health to convene a conference with the provincial and territorial ministers responsible for health for the purpose of establishing a pan-Canadian strategy to ensure clinical trials are started for the treatment of chronic cerebrospinal venous insufficiency (CCSVI) and to estimate the funding necessary to undertake those clinical trials in Canada and to track individuals who have been treated for CCSVI.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, provided by the Library of Parliament. You can also read the full text of the bill.

Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act
Routine Proceedings

March 26th, 2012 / 3:10 p.m.
See context

Liberal

Kirsty Duncan Etobicoke North, ON

moved for leave to introduce Bill C-410, An Act to establish a Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI).

Mr. Speaker, my bill aims to establish a pan-Canadian strategy for chronic cerebrospinal venous insufficiency, or CCSVI. The bill calls for the minister to convene a conference with the provincial and territorial ministers of health to establish a pan-Canadian strategy including: ensuring that proper health care is not refused to a person who is seeking or is obtaining treatment for CCSVI outside Canada; identifying the most appropriate level of clinical trials for treatment of CCSVI to place Canada at the forefront of international research; estimating the funding necessary for clinical trials and tracking individuals who have received the treatment; establishing an advisory panel composed of experts who have been actively engaged in diagnosis and treatment of CCSVI; and ensuring that clinical trials begin by July 1, 2012.

I hope all hon. members will support this bill.

(Motions deemed adopted, bill read the first time and printed)